TSBX

Turnstone Biologics
TSBX

Delisted

TSBX was delisted on the 8th of August, 2025.

Back to rankings

23 hedge funds and large institutions have $4.26M invested in Turnstone Biologics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

70% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 10

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$452K
2
+$9.83K
3
+$8.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$6.68K
5
HF
HRT Financial
New York
+$4K

Top Sellers

1
-$342K
2
-$257K
3
-$95.4K
4
Barclays
Barclays
United Kingdom
-$57K
5
Citigroup
Citigroup
New York
-$30.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity International
26
Fidelity International
Bermuda
–
Barclays
27
Barclays
United Kingdom
–
Citigroup
28
Citigroup
New York
–
Goldman Sachs
29
Goldman Sachs
New York
–
VF
30
Virtu Financial
New York
–
Morgan Stanley
31
Morgan Stanley
New York
–
1
2